MiNK Therapeutics shared a post on LinkedIn:
“MiNK Therapeutics will report Q3 2025 financial results and provide a corporate update on Friday, November 14 at 8:30 a.m. ET.
The webcast will review recent milestones advancing our allogeneic iNKT platform toward pivotal development.
Register to listen live.
Read Release.”
More Posts Featuring MiNK Therapeutic.